P&G's baby, feminine and family care segment posts fiscal Q4 net earnings of US$690M, down 2% from year ago, with net sales up 3% to US$4.82B; organic sales up 7%, with baby and feminine care led by higher pricing, offset by reduced operations in Russia

Sample article from our Tissue & Hygiene

CINCINNATI , July 29, 2022 (press release) –

FY ’22: Net Sales +5%; Organic Sales +7%; Diluted EPS +6%; Core EPS +3%

Q4 ’22: Net Sales +3%; Organic Sales +7%; Diluted and Core EPS +7%

The Procter & Gamble Company (NYSE:PG) reported fourth quarter and fiscal year 2022 results.

“Fiscal year 2022 was another strong year,” said Jon Moeller, Chairman of the Board, President and Chief Executive Officer. “The P&G team’s execution of our integrated strategies delivered strong top-line growth, earnings growth, and significant cash return to shareowners in the face of severe cost and operational headwinds. As we look forward to fiscal 2023, we expect another year of significant headwinds. We remain committed to our integrated strategies of superiority, productivity, constructive disruption and an agile and accountable organization structure. They remain the right strategies to step forward into the near-term challenges we are facing and continue to deliver balanced growth and value creation.”

$ billions, except EPS

Fiscal Year

GAAP

2022

2021

% Change

 

Non-GAAP*

2022

2021

% Change

Net Sales

$80.2

$76.1

5%

 

Organic Sales

n/a

n/a

7%

Diluted EPS

$5.81

$5.50

6%

 

Core EPS

$5.81

$5.66

3%

 

 

 

 

 

 

 

 

 

$ billions, except EPS

Fourth Quarter

GAAP

2022

2021

% Change

 

Non-GAAP*

2022

2021

% Change

Net Sales

$19.5

$18.9

3%

 

Organic Sales

n/a

n/a

7%

Diluted EPS

$1.21

$1.13

7%

 

Core EPS

$1.21

$1.13

7%

* Please refer to Exhibit 1 - Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures.

Fiscal Year 2022 Results

The Company reported fiscal year 2022 net sales of $80.2 billion, an increase of five percent versus the prior year. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased seven percent. The growth was broad-based driven by a two percent increase in organic volume, a four percent increase due to higher pricing and a one percent increase from positive mix.

Diluted net earnings per share were $5.81, an increase of six percent versus the prior year GAAP EPS, which included a charge for an early extinguishment of debt. Diluted net earnings per share increased three percent versus the prior year Core EPS. Currency-neutral net EPS increased five percent versus the prior year Core EPS.

The Company generated operating cash flow of $16.7 billion with an adjusted free cash flow productivity of 93%. The Company returned nearly $19 billion of value to shareholders in fiscal 2022 via $8.8 billion in dividend payments and $10 billion of share repurchases.

April-June Quarter Results

The Company reported fiscal year 2022 fourth quarter net sales of $19.5 billion, an increase of three percent versus the prior year. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased seven percent. The growth was driven by an eight percent increase in pricing, partially offset by a one percent decrease in volume primarily due to pandemic-related lockdowns in Greater China and reduced operations in Russia. Mix was neutral to net sales growth for the quarter.

Diluted net earnings per share were $1.21, an increase of seven percent versus the prior year. Operating cash flow was $3.7 billion with an adjusted free cash flow productivity of 99%.

April-June Quarter Business Discussion

April - June 2022

Volume

Foreign

Exchange

Price

Mix

Other (2)

Net Sales

Organic

Volume

Organic

Sales

Net Sales Drivers (1)

Beauty

(1)%

(3)%

6%

(4)%

1%

(1)%

(2)%

—%

Grooming

(3)%

(6)%

6%

(1)%

1%

(3)%

(2)%

3%

Health Care

—%

(4)%

5%

4%

—%

5%

—%

9%

Fabric & Home Care

(1)%

(5)%

10%

—%

—%

4%

(1)%

9%

Baby, Feminine & Family Care

—%

(3)%

6%

1%

(1)%

3%

—%

7%

Total P&G

(1)%

(4)%

8%

—%

—%

3%

(1)%

7%

(1)

 

Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

(2)

 

Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

  • Beauty segment organic sales were unchanged versus year ago. Hair Care organic sales increased low single digits due to increased pricing, partially offset by volume declines due to pandemic-related lockdowns in Greater China and reduced operations in Russia. Skin and Personal Care organic sales decreased low single digits driven by negative mix due to decline of the super-premium SK-II brand (impacted by pandemic-related lockdowns in China), partially offset by increased pricing and volume growth from innovation.
  • Grooming segment organic sales increased three percent versus year ago. Shave Care organic sales increased mid-single digits due to increased pricing, partially offset by volume declines from pandemic-related lockdowns in Greater China. Appliances organic sales decreased high-single digits due primarily to market contraction versus a base period that benefited from pandemic-related consumption increases, partially offset by positive product mix.
  • Health Care segment organic sales increased nine percent for the quarter. Oral Care organic sales increased high single digits due to increased net pricing and positive product mix, partially offset by lower volumes due to pandemic-related lockdowns in Greater China and market contraction in developed markets. Personal Health Care organic sales increased mid-teens. Growth was broad-based driven by positive mix from the disproportionate growth of respiratory products, increased net pricing and volume growth due to a stronger respiratory season versus year ago.
  • Fabric and Home Care segment organic sales increased nine percent for the quarter. Fabric Care organic sales increased double digits driven primarily by higher net pricing. Volume growth from innovation was offset primarily by declines due to reduced operations in Russia. Home Care organic sales increased low single digits due to increased pricing and positive product mix, partially offset by market contraction versus a base period that benefited from pandemic-related consumption increases.
  • Baby, Feminine and Family Care segment organic sales increased seven percent versus year ago. Baby Care organic sales increased mid-single digits due to increased pricing, partially offset by lower volumes due to reduced operations in Russia and competitive activity in developed markets. Feminine Care organic sales increased low teens with growth in all regions. The growth was driven primarily by increased net pricing and positive product mix, partially offset by lower volumes due to reduced operations in Russia. Family Care organic sales increased mid-single digits due to increased net pricing and volume growth from innovation and increased promotional activity.

Diluted net earnings per share were $1.21 for the quarter, an increase of seven percent versus the prior year. This was driven by an increase in net sales and a reduction in shares outstanding, partially offset by a reduction in operating margin. Currency-neutral net EPS increased 12% versus the prior year.

Gross margin for the quarter decreased 370 basis points versus year ago, 330 basis points on a currency-neutral basis. The decline was driven by 450 basis points of increased commodity costs, 80 basis points of higher freight costs, 40 basis points of other cost increases net of productivity savings, 20 basis points of product and package reinvestments, and 130 basis points of negative product mix. These were partially offset by 390 basis points of pricing benefit.

Selling, general and administrative expense (SG&A) as a percentage of sales decreased 340 basis points versus the prior year, 350 basis points on a currency-neutral basis. The decrease was driven by 180 basis points of leverage benefit due to increased sales and 200 basis points of overhead savings and marketing efficiencies, partially offset by 30 basis points of other impacts.

Operating margin for the quarter decreased 30 basis points versus the prior year and increased 20 basis points on a currency-neutral basis.

Fiscal Year 2023 Guidance

P&G expects fiscal year 2023 all-in sales growth in the range of in-line to up two percent versus the prior fiscal year. Foreign exchange is expected to be a headwind of approximately three percentage points to all-in sales growth. The Company expects organic sales growth in the range of three to five percent.

P&G expects fiscal 2023 diluted net earnings per share growth in the range of in-line to up four percent versus fiscal 2022 EPS of $5.81. At the mid-point of the range, this outlook equates to $5.93 per share, or an increase of two percent.

The Company said its current outlook estimates headwinds of approximately $3.3 billion after-tax from unfavorable foreign exchange, higher commodity costs and higher freight costs. The combined impact of commodities, freight and foreign exchange is approximately a $1.33 per share headwind to fiscal year 2023 EPS, or a 23 percentage point headwind to EPS growth. P&G added that it expects these costs and currency headwinds will be most pronounced in the first half of its fiscal year.

The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures without unreasonable efforts given the unpredictability of the timing and amounts of discrete items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.

P&G said it expects a core effective tax rate in the range of 19% to 19.5% in fiscal 2023.

Capital spending is estimated to be approximately five percent of fiscal 2023 net sales.

P&G is targeting adjusted free cash flow productivity of 90% and expects to pay over $9 billion in dividends and to repurchase $6 billion to $8 billion of common shares in fiscal 2023.

Forward-Looking Statements

Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward­ looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war (including the Russia­ Ukraine War) or terrorism or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, labor and employment, antitrust, privacy and data protection, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company's overall business strategy and financial objectives, without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (17) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns (including COVID-19); (18) the ability to manage the uncertainties, sanctions and economic effects from the war between Russia and Ukraine; and (19) the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

Three Months Ended June 30

 

Twelve Months Ended June 30

 

2022

 

2021

 

% Chg

 

2022

 

2021

 

% Chg

NET SALES

$

19,515

 

 

$

18,946

 

 

3%

 

$

80,187

 

 

$

76,118

 

 

5%

Cost of products sold

 

10,802

 

 

 

9,791

 

 

10%

 

 

42,157

 

 

 

37,108

 

 

14%

GROSS PROFIT

 

8,713

 

 

 

9,155

 

 

(5)%

 

 

38,030

 

 

 

39,010

 

 

(3)%

Selling, general and administrative expense

 

5,115

 

 

 

5,615

 

 

(9)%

 

 

20,217

 

 

 

21,024

 

 

(4)%

OPERATING INCOME

 

3,598

 

 

 

3,540

 

 

2%

 

 

17,813

 

 

 

17,986

 

 

(1)%

Interest expense

 

(115

)

 

 

(117

)

 

(2)%

 

 

(439

)

 

 

(502

)

 

(13)%

Interest income

 

21

 

 

 

15

 

 

40%

 

 

51

 

 

 

45

 

 

13%

Other non-operating income, net

 

146

 

 

 

126

 

 

16%

 

 

570

 

 

 

86

 

 

563%

EARNINGS BEFORE INCOME TAXES

 

3,650

 

 

 

3,564

 

 

2%

 

 

17,995

 

 

 

17,615

 

 

2%

Income taxes

 

592

 

 

 

656

 

 

(10)%

 

 

3,202

 

 

 

3,263

 

 

(2)%

NET EARNINGS

 

3,058

 

 

 

2,908

 

 

5%

 

 

14,793

 

 

 

14,352

 

 

3%

Less: Net earnings/(loss) attributable to non controlling interests

 

6

 

 

 

2

 

 

N/A

 

 

51

 

 

 

46

 

 

11%

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE

$

3,052

 

 

$

2,906

 

 

5%

 

$

14,742

 

 

$

14,306

 

 

3%

 

 

 

 

 

 

 

 

 

 

 

 

EFFECTIVE TAX RATE

 

16.2

%

 

 

18.4

%

 

 

 

 

17.8

%

 

 

18.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET EARNINGS PER COMMON SHARE: (1)

 

 

 

 

 

 

 

 

 

 

 

Basic

$

1.24

 

 

$

1.16

 

 

7%

 

$

6.00

 

 

$

5.69

 

 

5%

Diluted

$

1.21

 

 

$

1.13

 

 

7%

 

$

5.81

 

 

$

5.50

 

 

6%

 

 

 

 

 

 

 

 

 

 

 

 

DIVIDENDS PER COMMON SHARE

$

0.9133

 

 

$

0.8698

 

 

5%

 

$

3.5230

 

 

$

3.2419

 

 

9%

Diluted Weighted Average Common Shares Outstanding

 

2,523.3

 

 

 

2,573.1

 

 

 

 

 

2,539.1

 

 

 

2,601.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPARISONS AS A % OF NET SALES

 

 

 

 

Basis Pt Change

 

 

 

 

 

Basis Pt Change

Gross margin

 

44.6

%

 

 

48.3

%

 

(370)

 

 

47.4

%

 

 

51.2

%

 

(380)

Selling, general and administrative expense

 

26.2

%

 

 

29.6

%

 

(340)

 

 

25.2

%

 

 

27.6

%

 

(240)

Operating margin

 

18.4

%

 

 

18.7

%

 

(30)

 

 

22.2

%

 

 

23.6

%

 

(140)

Earnings before income taxes

 

18.7

%

 

 

18.8

%

 

(10)

 

 

22.4

%

 

 

23.1

%

 

(70)

Net earnings

 

15.7

%

 

 

15.3

%

 

40

 

 

18.4

%

 

 

18.9

%

 

(50)

Net earnings attributable to Procter & Gamble

 

15.6

%

 

 

15.3

%

 

30

 

 

18.4

%

 

 

18.8

%

 

(40)

(1)

 

Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

     

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

Three Months Ended June 30, 2022

 

Net Sales

 

% Change

Versus Year

Ago

 

Earnings/(Loss) Before

Income Taxes

 

% Change

Versus Year

Ago

 

Net Earnings/(Loss)

 

% Change

Versus Year

Ago

Beauty

$3,461

 

(1)%

 

$733

 

(16)%

 

$578

 

(18)%

Grooming

1,608

 

(3)%

 

388

 

(14)%

 

307

 

(16)%

Health Care

2,510

 

5%

 

393

 

(3)%

 

291

 

(1)%

Fabric & Home Care

6,876

 

4%

 

1,445

 

11%

 

1,089

 

9%

Baby, Feminine & Family Care

4,821

 

3%

 

914

 

(1)%

 

690

 

(2)%

Corporate

239

 

N/A

 

(223)

 

N/A

 

103

 

N/A

Total Company

$19,515

 

3%

 

$3,650

 

2%

 

$3,058

 

5%

 

Three Months Ended June 30, 2022

 

(Percent Change vs. Year Ago) (1)

 

Volume with

Acquisitions &

Divestitures

 

Volume Excluding

Acquisitions &

Divestitures

 

Foreign

Exchange

 

Price

 

Mix

 

Other (2)

 

Net Sales

Growth

Beauty

(1)%

 

(2)%

 

(3)%

 

6%

 

(4)%

 

1%

 

(1)%

Grooming

(3)%

 

(2)%

 

(6)%

 

6%

 

(1)%

 

1%

 

(3)%

Health Care

—%

 

—%

 

(4)%

 

5%

 

4%

 

—%

 

5%

Fabric & Home Care

(1)%

 

(1)%

 

(5)%

 

10%

 

—%

 

—%

 

4%

Baby, Feminine & Family Care

—%

 

—%

 

(3)%

 

6%

 

1%

 

(1)%

 

3%

Total Company

(1)%

 

(1)%

 

(4)%

 

8%

 

—%

 

—%

 

3%

 

Twelve Months Ended June 30, 2022

 

Net Sales

 

% Change

Versus Year

Ago

 

Earnings/(Loss) Before

Income Taxes

 

% Change

Versus Year

Ago

 

Net Earnings/(Loss)

 

% Change

Versus Year

Ago

Beauty

$14,740

 

2%

 

$3,946

 

(2)%

 

$3,160

 

(2)%

Grooming

6,587

 

2%

 

1,835

 

6%

 

1,490

 

4%

Health Care

10,824

 

9%

 

2,618

 

9%

 

2,006

 

8%

Fabric & Home Care

27,556

 

6%

 

5,729

 

(4)%

 

4,386

 

(5)%

Baby, Feminine & Family Care

19,736

 

5%

 

4,267

 

(10)%

 

3,266

 

(10)%

Corporate

744

 

N/A

 

(400)

 

N/A

 

485

 

N/A

Total Company

$80,187

 

5%

 

$17,995

 

2%

 

$14,793

 

3%

 

Twelve Months Ended June 30, 2022

 

(Percent Change vs. Year Ago) (1)

 

Volume with

Acquisitions &

Divestitures

 

Volume Excluding

Acquisitions &

Divestitures

 

Foreign

Exchange

 

Price

 

Mix

 

Other (2)

 

Net Sales

Growth

Beauty

—%

 

—%

 

—%

 

3%

 

(1)%

 

—%

 

2%

Grooming

—%

 

—%

 

(3)%

 

5%

 

—%

 

—%

 

2%

Health Care

4%

 

4%

 

(1)%

 

3%

 

3%

 

—%

 

9%

Fabric & Home Care

3%

 

3%

 

(2)%

 

5%

 

—%

 

—%

 

6%

Baby, Feminine & Family Care

1%

 

1%

 

(1)%

 

4%

 

1%

 

—%

 

5%

Total Company

2%

 

2%

 

(2)%

 

4%

 

1%

 

—%

 

5%

(1)

 

Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

(2)

 

Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

     

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Statements of Cash Flows

 

Twelve Months Ended June 30

 

2022

 

2021

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR

$

10,288

 

 

$

16,181

 

OPERATING ACTIVITIES

 

 

 

Net earnings

 

14,793

 

 

 

14,352

 

Depreciation and amortization

 

2,807

 

 

 

2,735

 

Loss on early extinguishment of debt

 

 

 

 

512

 

Share-based compensation expense

 

528

 

 

 

540

 

Deferred income taxes

 

(402

)

 

 

(258

)

Loss/(gain) on sale of assets

 

(85

)

 

 

(16

)

Change in accounts receivable

 

(694

)

 

 

(342

)

Change in inventories

 

(1,247

)

 

 

(309

)

Change in accounts payable, accrued and other liabilities

 

1,429

 

 

 

1,391

 

Change in other operating assets and liabilities

 

(635

)

 

 

(369

)

Other

 

229

 

 

 

135

 

TOTAL OPERATING ACTIVITIES

 

16,723

 

 

 

18,371

 

INVESTING ACTIVITIES

 

 

 

Capital expenditures

 

(3,156

)

 

 

(2,787

)

Proceeds from asset sales

 

110

 

 

 

42

 

Acquisitions, net of cash acquired

 

(1,381

)

 

 

(34

)

Purchases of investment securities

 

 

 

 

(55

)

Change in other investments

 

3

 

 

 

 

TOTAL INVESTING ACTIVITIES

 

(4,424

)

 

 

(2,834

)

FINANCING ACTIVITIES

 

 

 

Dividends to shareholders

 

(8,770

)

 

 

(8,263

)

Additions to short-term debt with original maturities of more than three months

 

10,411

 

 

 

7,675

 

Reductions in short-term debt with original maturities of more than three months

 

(11,478

)

 

 

(7,577

)

Additions/(reductions) in other short-term debt

 

917

 

 

 

(3,431

)

Additions to long-term debt

 

4,385

 

 

 

4,417

 

Reductions of long-term debt

 

(2,343

)

 

 

(4,987

)

Treasury stock purchases

 

(10,003

)

 

 

(11,009

)

Impact of stock options and other

 

2,005

 

 

 

1,644

 

TOTAL FINANCING ACTIVITIES

 

(14,876

)

 

 

(21,531

)

EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

 

(497

)

 

 

101

 

CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

 

(3,074

)

 

 

(5,893

)

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR

$

7,214

 

 

$

10,288

 

               

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Condensed Consolidated Balance Sheets

 

June 30, 2022

 

June 30, 2021

Cash and cash equivalents

$

7,214

 

$

10,288

Accounts receivable

 

5,143

 

 

4,725

Inventories

 

6,924

 

 

5,983

Prepaid expenses and other current assets

 

2,372

 

 

2,095

TOTAL CURRENT ASSETS

 

21,653

 

 

23,091

PROPERTY, PLANT AND EQUIPMENT, NET

 

21,195

 

 

21,686

GOODWILL

 

39,700

 

 

40,924

TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET

 

23,679

 

 

23,642

OTHER NONCURRENT ASSETS

 

10,981

 

 

9,964

TOTAL ASSETS

$

117,208

 

$

119,307

 

 

 

 

Accounts payable

$

14,882

 

$

13,720

Accrued and other liabilities

 

9,554

 

 

10,523

Debt due within one year

 

8,645

 

 

8,889

TOTAL CURRENT LIABILITIES

 

33,081

 

 

33,132

LONG-TERM DEBT

 

22,848

 

 

23,099

DEFERRED INCOME TAXES

 

6,809

 

 

6,153

OTHER NONCURRENT LIABILITIES

 

7,616

 

 

10,269

TOTAL LIABILITIES

 

70,354

 

 

72,653

TOTAL SHAREHOLDERS' EQUITY

 

46,854

 

 

46,654

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$

117,208

 

$

119,307

           

The Procter & Gamble Company

Exhibit 1: Non-GAAP Measures

In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures used in Procter & Gamble's July 29, 2022 earnings release and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.

The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following item:

Early debt extinguishment charge: During fiscal year 2021, the Company recorded an after tax charge of $427 million ($512 million before tax) due to early extinguishment of certain long-term debt. This charge represents the difference between the reacquisition price and the par value of the debt extinguished.

We do not view the above item to be part of our sustainable results and its exclusion from Core earnings measures provides a more comparable measure of year-on-year results. This item is also excluded when evaluating senior management in determining their at-risk compensation.

Organic sales growth*: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis.

Currency-neutral operating profit margin: Currency-neutral operating profit margin is a measure of the Company's operating margin excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company’s operating efficiency over time.

Currency-neutral gross margin: Currency-neutral gross margin is a measure of the Company's gross margin excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company’s operating efficiency over time.

Currency-neutral selling, general and administrative (SG&A) expense as a percentage of net sales: Currency-neutral SG&A expense as a percentage of net sales is a measure of the Company's selling, general and administrative expenses excluding the incremental current year impact of foreign exchange. Management believes this non-GAAP measure provides a supplemental perspective to the Company's operating efficiency over time.

Core EPS*: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share adjusted as indicated. Management views these non-GAAP measures as a useful supplemental measure of Company performance over time. This measure is also used when evaluating senior management in determining their at-risk compensation.

Currency-neutral EPS: Currency-neutral EPS is a measure of the Company's EPS excluding the incremental current year impact of foreign exchange. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time.

Free cash flow and adjusted free cash flow: Free cash flow is defined as operating cash flow less capital spending. Adjusted free cash flow is defined as operating cash flow less capital spending and adjusted for the payment of the transitional tax resulting from the comprehensive U.S. legislation commonly referred to as the Tax Cuts and Jobs Act in December 2017 (the "U.S. Tax Act"). Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.

Free cash flow productivity and adjusted free cash flow productivity*: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the charges for early debt extinguishment (which are not considered part of our ongoing operations). Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, in allocating financial resources and for budget planning purposes. The Company's long-term target is to generate annual adjusted free cash flow productivity at or above 90%.

* Measure is used to evaluate senior management and is a factor in determining their at-risk compensation.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Reconciliation of Non-GAAP Measures

 

Three Months Ended

June 30, 2022

 

Three Months Ended

June 30, 2021

 

AS REPORTED (GAAP)

 

AS REPORTED (GAAP)

COST OF PRODUCTS SOLD

$

10,802

 

 

$

9,791

 

GROSS PROFIT

 

8,713

 

 

 

9,155

 

GROSS MARGIN

 

44.6

%

 

 

48.3

%

CURRENCY IMPACT TO GROSS MARGIN

 

(0.4

)%

 

 

CURRENCY-NEUTRAL GROSS MARGIN

 

45.0

%

 

 

SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE

 

5,115

 

 

 

5,615

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

26.2

%

 

 

29.6

%

CURRENCY IMPACT TO SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

(0.1

)%

 

 

CURRENCY-NEUTRAL SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

26.1

%

 

 

OPERATING INCOME

 

3,598

 

 

 

3,540

 

OPERATING PROFIT MARGIN

 

18.4

%

 

 

18.7

%

CURRENCY IMPACT TO OPERATING MARGIN

 

0.5

%

 

 

CURRENCY-NEUTRAL OPERATING MARGIN

 

18.9

%

 

 

NET EARNINGS ATTRIBUTABLE TO P&G

 

3,052

 

 

 

2,906

 

 

 

 

 

DILUTED NET EARNINGS PER COMMON SHARE (1)

$

1.21

 

 

$

1.13

 

CURRENCY IMPACT TO EARNINGS

$

(0.06

)

 

 

CURRENCY-NEUTRAL EPS

$

1.27

 

 

 

DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

 

2,523.3

 

 

 

2,573.1

 

COMMON STOCK OUTSTANDING AS OF JUNE 30, 2022

 

2,393.9

 

 

 

(1)

 

Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

     
 

CHANGE IN CURRENT YEAR REPORTED (GAAP) MEASURES VERSUS PRIOR YEAR NON-GAAP (CORE) MEASURES (1)

 
 

GROSS MARGIN (1)

 

(370

)

 

BPS

 
 

CURRENCY-NEUTRAL GROSS MARGIN

 

(330

)

 

BPS

 
 

SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

(340

)

 

BPS

 
 

CURRENCY-NEUTRAL SELLING GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

(350

)

 

BPS

 
 

OPERATING PROFIT MARGIN

 

(30

)

 

BPS

 
 

CURRENCY-NEUTRAL OPERATING PROFIT MARGIN

 

20

 

 

BPS

 
 

EPS

 

7

%

 

 

 
 

CURRENCY-NEUTRAL EPS

 

12

%

 

 

 

(1)

 

Change versus year ago is calculated based on As Reported (GAAP) values for the three months ended June 30, 2022 versus the Non-GAAP (Core) values for the three months ended June 30,2021.

     
 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Reconciliation of Non-GAAP Measures

 

Twelve Months Ended

June 30, 2022

 

Twelve Months Ended June 30, 2021

 

AS REPORTED

(GAAP)

 

AS REPORTED

(GAAP)

 

EARLY DEBT

EXTINGUISHMENT

 

NON-GAAP

(CORE)

COST OF PRODUCTS SOLD

$

42,157

 

 

$

37,108

 

 

$

 

 

$

37,108

 

GROSS PROFIT

 

38,030

 

 

 

39,010

 

 

 

 

 

 

39,010

 

GROSS MARGIN

 

47.4

%

 

 

51.2

%

 

 

%

 

 

51.2

%

SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE

 

20,217

 

 

 

21,024

 

 

 

 

 

 

21,024

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE AS A % OF NET SALES

 

25.2

%

 

 

27.6

%

 

 

%

 

 

27.6

%

OPERATING INCOME

 

17,813

 

 

 

17,986

 

 

 

 

 

 

17,986

 

OPERATING PROFIT MARGIN

 

22.2

%

 

 

23.6

%

 

 

%

 

 

23.6

%

NET EARNINGS ATTRIBUTABLE TO P&G

 

14,742

 

 

 

14,306

 

 

 

427

 

 

 

14,733

 

 

 

 

 

 

 

 

 

DILUTED NET EARNINGS PER COMMON SHARE (1)

$

5.81

 

 

$

5.50

 

 

$

0.16

 

 

$

5.66

 

CURRENCY IMPACT TO EARNINGS

$

0.11

 

 

 

 

 

 

 

CURRENCY-NEUTRAL CORE EPS

$

5.92

 

 

 

 

 

 

 

DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

 

2,539.1

 

 

 

2,601.0

 

 

 

 

 

COMMON SHARES OUTSTANDING - JUNE 30, 2022

 

2,393.9

 

 

 

 

 

 

 

(1)

 

Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

     
     
 

CHANGE IN CURRENT YEAR REPORTED (GAAP) AND NON GAAP MEASURES VERSUS PRIOR YEAR REPORTED (GAAP) MEASURES

 
 

EPS

3 %

 

 
 

CURRENCY NEUTRAL EPS

5 %

 

 
         

Organic sales growth:

The reconciliation of reported sales growth to organic sales is as follows:

April - June 2022

Net Sales

Growth

 

Foreign

Exchange

Impact

 

Acquisition &

Divestiture

Impact/Other*

 

Organic Sales

Growth

Beauty

(1)%

 

3%

 

(2)%

 

—%

Grooming

(3)%

 

6%

 

—%

 

3%

Health Care

5%

 

4%

 

—%

 

9%

Fabric & Home Care

4%

 

5%

 

—%

 

9%

Baby, Feminine & Family Care

3%

 

3%

 

1%

 

7%

Total Company

3%

 

4%

 

—%

 

7%

FY 2022

Net Sales

Growth

 

Foreign

Exchange

Impact

 

Acquisition &

Divestiture

Impact/Other*

 

Organic Sales

Growth

Total Company

5%

 

2%

 

—%

 

7%

*

 

Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

     
             

Total Company

 

Net Sales Growth

 

Combined Foreign Exchange &

Acquisition/Divestiture Impact

 

Organic Sales

Growth

FY 2023 (Estimate)

 

+0% to +2%

 

+3%

 

+3% to +5%

             
             

Adjusted free cash flow (dollars in millions):

Three Months Ended June 30, 2022

Operating Cash Flow

 

Capital Spending

 

Free Cash Flow

$3,713

 

$(692)

 

$3,021

         

Twelve Months Ended June 30, 2022

Operating Cash Flow

 

Capital Spending

 

U.S. Tax Act Payments

 

Adjusted Free Cash Flow

$16,723

 

$(3,156)

 

$225

 

$13,792

             
             

Adjusted free cash flow productivity (dollars in millions):

Three Months Ended June 30, 2022

Free Cash Flow

 

Net Earnings

 

Free Cash Flow Productivity

$3,021

 

$3,058

 

99%

         

Twelve Months Ended June 30, 2022

Adjusted Free Cash Flow

 

Net Earnings

 

Adjusted Free Cash Flow

Productivity

$13,792

 

$14,793

 

93%

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.